Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders
Journal article published in 2009 by
Jan Cerny,
Marek Trneny 
,
Alena Slavickova,
Robert Pytlik,
Jana Salkova,
Veronika Valkova,
Qin Liu,
JeanMarie Houghton,
Pavel Klener
,
Alena Slavickova,
Robert Pytlik,
Jana Salkova,
Veronika Valkova,
Qin Liu,
JeanMarie Houghton,
Pavel Klener
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 